ArticleRadiation oncology (London, England)2022
Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma.
Yirui Zhai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it